Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis
- PMID: 6130293
- DOI: 10.1016/s0140-6736(83)91685-9
Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis
Abstract
48 patients with rapidly progressive glomerulonephritis were treated by a regimen of intensive plasma exchange, steroids, and cytotoxic drugs. All required dialysis before immunosuppressive treatment was started, and all had 50% or more of their glomeruli affected by crescent formation. Renal function was not recovered in any of the 21 patients with anti-glomerular basement membrane antibody disease. In contrast 63% of patients without these autoantibodies recovered renal function. Plasma creatinine remained stable over prolonged follow-up (6-60 months) in all but 1 of the 10 late survivors. There was no correlation between the extent of crescent formation and recovery of renal function in those patients without circulating anti-glomerular basement membrane antibodies.
Similar articles
-
Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane.Int J Artif Organs. 1983 Jul;6 Suppl 1:15-8. Int J Artif Organs. 1983. PMID: 6642729
-
Plasma exchange and immunosuppressive drugs in the management of severe glomerulonephritis.Prog Clin Biol Res. 1982;106:91-104. Prog Clin Biol Res. 1982. PMID: 6757955 No abstract available.
-
MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.Ren Fail. 2011;33(6):626-31. doi: 10.3109/0886022X.2011.581401. Epub 2011 May 20. Ren Fail. 2011. PMID: 21599422
-
[Anti-basement-membrane antibody mediated, rapidly progressive, glomerulonephritis. Diagnostic and therapeutic strategy based on a retrospective study of 14 cases].Ann Med Interne (Paris). 1990;141(5):409-15. Ann Med Interne (Paris). 1990. PMID: 2256583 Review. French.
-
Anti-Glomerular Basement Membrane Disease.Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1162-1172. doi: 10.2215/CJN.01380217. Epub 2017 May 17. Clin J Am Soc Nephrol. 2017. PMID: 28515156 Free PMC article. Review.
Cited by
-
The treatment of glomerulonephritis in children.Pediatr Nephrol. 1988 Apr;2(2):247-55. doi: 10.1007/BF00862601. Pediatr Nephrol. 1988. PMID: 3153019 Review.
-
Towards a more rapid diagnosis of rapidly progressive glomerulonephritis.BMJ. 1990 Aug 11;301(6747):329-31. doi: 10.1136/bmj.301.6747.329. BMJ. 1990. PMID: 1975508 Free PMC article.
-
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis.Semin Immunopathol. 2007 Nov;29(4):459-74. doi: 10.1007/s00281-007-0093-0. Epub 2007 Oct 18. Semin Immunopathol. 2007. PMID: 17943286 Review.
-
Treatment of non anti-GBM-antibody mediated, rapidly progressive glomerulonephritis by plasmapheresis and immunosuppression.Klin Wochenschr. 1986 Mar 3;64(5):231-8. doi: 10.1007/BF01711654. Klin Wochenschr. 1986. PMID: 3702282
-
Renal vasculitis: a review.J R Soc Med. 1985 Aug;78(8):667-71. doi: 10.1177/014107688507800814. J R Soc Med. 1985. PMID: 3894662 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical